Concepedia

Author

G. Lelli

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Also Known As

G Lelli, G. Lelli, GIORGIO LELLI, Giorgio Lelli, James A. Hayman

80

Publications

1.3K

Citations

15

H-Index

41

Concepts

All Affiliations

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaCasa Sollievo della SofferenzaIstituti di Ricovero e Cura a Carattere ScientificoFondazione Salvatore MaugeriUniversity of Ferrara
GL

About

G. Lelli is an author at IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

13

896

2

Endocrinology

2

2

30

3

Immunology

2

2

107

4

Health Sciences

1

1

35

5

Gastroenterology

1

1

13

G. Lelli

×

22

Publications

1.2K

Citations

15

H-Index

YearCitations

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

J L Pico, Giovanni Rosti, A. Kramar,

Annals of Oncology

2005

285

Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation

Laura Astolfi, Sara Ghiselli, Valeria Guaran,

Oncology Reports

2013

227

Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara<sup>®</sup>) in breast cancer patients

C. Pfister, Antonio Martoni, Carlo Zamagni,

Biopharmaceutics & Drug Disposition

2001

98

Transitional Cell Carcinoma of the Upper Urinary Tract: Evaluation of Prognostic Factors by Histopathology and Flow Cytometric Analysis

Francesco Corrado, Claudio Ferri, D Mannini,

The Journal of Urology

1991

87

Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients

Roberta Rizzo, Federica Spaggiari, Monica Indelli,

Breast Cancer Research and Treatment

2010

62

Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)

Andrea Martoni, Carmine Pinto, Francesca Di Fabio,

European Journal of Cancer

2006

45

Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer

Andrea Martoni, Francesca Di Fabio, M. Guaraldi,

American Journal of Clinical Oncology

2001

45

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Jean‐François Emile, Catherine Julié, Karine Le Malicot,

European Journal of Cancer

2017

45

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer

Sara Cresta, Giacomo Grasselli, Mauro Mansutti,

Annals of Oncology

2004

38

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

Alba A. Brandes, Enrico Franceschi, Mario Ermani,

Neuro-Oncology Practice

2014

35

Page 1